Upregulated NPM1 is an independent biomarker to predict progression and prognosis of oral squamous cell carcinomas in Taiwan.
Hsin-Hui PengHui-Hsin KoNai-Chi ChiYi-Ping WangHsiang-Chieh LeePei-Yao PanMark Yen-Ping KuoShih-Jung ChengPublished in: Head & neck (2019)
Upregulated NPM1 is an independent biomarker of poor prognosis and NPM1 inhibitors may be promising in molecular targeted therapy against OSCC.